-
Intellia Therapeutics (NASDAQ:NTLA) Earns Buy Rating from Analysts at HC Wainwright
来源: Buzz FX / 06 3月 2025 08:51:15 America/Chicago
Intellia Therapeutics (NASDAQ:NTLA) Earns Buy Rating from Analysts at HC Wainwright Written by MarketBeat March 6, 2025 Share Link copied to clipboard. Equities researchers at HC Wainwright assumed coverage on shares of Intellia Therapeutic
Read more...